1. |
Guo T, Zhao S, Wang P, et al. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma. Oncotarget, 2017, 8(29): 48110-48125.
|
2. |
Wei X, Zhang K, Qin H, et al. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma. BMC Cancer, 2018, 18(1): 600.
|
3. |
Ferrer I, Quintanal-Villalonga Á, Molina-Pinelo S, et al. MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma. J Exp Clin Cancer Res, 2018, 37(1): 195.
|
4. |
Liao M, Liu Q, Li B, et al. A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma. Cancer Sci, 2018, 109(12): 4033-4044.
|
5. |
Zhang Y, Sun L, Gao X, et al. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma. BMC Cancer, 2019, 19(1): 670.
|
6. |
He SY, Xi WJ, Wang X, et al. Identification of a combined RNA prognostic signature in adenocarcinoma of the lung. Med Sci Monit, 2019, 25: 3941-3956.
|
7. |
Ding F, Wang D, Li XK, et al. Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma. Thorac Cancer, 2018, 9(7): 827-835.
|
8. |
Lu JC, Wei QY, Bondy ML, et al. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged ≤55 years. Breast Cancer Res Treat, 2008, 110(2): 357-366.
|
9. |
Podralska M, Ziółkowska-Suchanek I, Żurawek M, et al. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the Polish population. BMC Cancer, 2018, 18(1): 452.
|
10. |
Srivastava N, Manvati S, Srivastava A, et al. miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention. Breast Cancer Res, 201, 13(2): R39.
|
11. |
Okabe A, Kiriyama Y, Suzuki S, et al. Short-term detection of gastric genotoxicity using the DNA double-strand break marker γ-H2AX. J Toxicol Pathol, 2019, 32(2): 91-99.
|
12. |
Liu J, Li W, Zhang J, et al. Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma. PeerJ, 2019, 7: e8021.
|
13. |
Yi S, Huang XY, Liu Y, et al. Identification of key candidate genes and pathways for relationship between ovarian cancer and diabetes mellitus using bioinformatical analysis. Asian Pac J Cancer Prev, 2019, 20(1): 145-155.
|
14. |
Bretherick KL, Schuetz JM, Morton LM, et al. Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma. PLoS One, 2013, 8(9): e74619.
|
15. |
Ouillette P, Fossum S, Parkin B, et al. Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks. Clin Cancer Res, 2010, 16(3): 835-847.
|
16. |
Carén H, Kryh H, Nethander M, et al. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proc Natl Acad Sci USA, 2010, 107(9): 4323-4328.
|
17. |
Huang R, Liu Z, Tian T, et al. The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma. Biosci Rep, 2020, 40(3): BSR20200049.
|
18. |
Ma H, Liu C, Zhang S, et al. miR-328-3p promotes migration and invasion by targeting H2AFX in head and neck squamous cell carcinoma. J Cancer, 2021, 12(21): 6519-6530.
|
19. |
Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res, 2008, 18(1): 134-147.
|
20. |
Kuo LJ, Yang LX. Gamma-H2AX - a novel biomarker for DNA double-strand breaks. In Vivo, 2008, 22(3): 305-309.
|
21. |
Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability-an evolving hallmark of cancer. Nat Rev Mol Cell Biol, 2010, 11(3): 220-228.
|
22. |
Wm B, Redon CE, Dickey JS, et al. GammaH2AX and cancer. Nat Rev Cancer, 2008, 8(12): 957-967.
|
23. |
Wu C, Tong L, Wu C, et al. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: a bioinformatic analysis based on the TCGA dataset. Cancer Med, 2020, 9(8): 2631-2642.
|
24. |
Celeste A, Difilippantonio S, Difilippantonio MJ, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell, 2003, 114(3): 371-383.
|
25. |
Bassing CH, Suh H, Ferguson DO, et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell, 2003, 114(3): 359-370.
|
26. |
Georgoulis A, Vorgias CE, Chrousos GP, et al. Genome instability and γH2AX. Int J Mol Sci, 2017, 18(9): 1979.
|
27. |
Palla VV, Karaolanis G, Katafigiotis I, et al. gamma-H2AX: can it be established as a classical cancer prognostic factor?. Tumour Biol, 2017, 39(3): 1010428317695931.
|
28. |
Corujo D, Buschbeck M. Post-translational modifications of H2A histone variants and their role in cancer. Cancers (Basel), 2018, 10(3): 59.
|
29. |
Evert M, Frau M, Tomasi ML, et al. Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value. Br J Cancer, 2013, 109(10): 2654-2664.
|
30. |
Zhang Z, Li J, He T, et al. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma. Cancer Sci, 2019, 110(9): 2905-2923.
|
31. |
Ma CG, Xu WH, Xu Y, et al. Identification and validation of novel metastasis-related signatures of clear cell renal cell carcinoma using gene expression databases. Am J Transl Res, 2020, 12(8): 4108-4126.
|
32. |
Zhang L, Chen J, Yang H, et al. Multiple microarray analyses identify key genes associated with the development of non-small cell lung cancer from chronic obstructive pulmonary disease. J Cancer, 2021, 12(4): 996-1010.
|
33. |
Gao X, Tang RX, Xie QN, et al. The clinical value of miR-193a-3p in non-small cell lung cancer and its potential molecular mechanism explored in silico using RNA-sequencing and microarray data. FEBS Open Bio, 2018, 8(1): 94-109.
|